Ricardo Abreu failed a drug test while serving a two-year suspension from USADA, but that doesn’t matter to the UFC middleweight after all.
"Demente", who is suspended until June 2018 after testing positive for anabolic steroid metabolites norandrosterone and 19-noretiocholanolone in June of last year, told MMA Fighting on Friday that he expected to fail a drug test and announced his decision to retire from the sport to focus on his health and family after battling depression. Combate first reported Abreu’s retirement.
The reasons why Abreu failed a drug test is that he was under treatment, he explains.